Related content

Temozolomide with or without Radiotherapy in Patients with Newly Diagnosed Glioblastoma Multiforme: A Meta-Analysis

By  

European Neurology, Vol. 77, Iss. 3-4, 2017-02 ,pp. : 201-210

Karger

Access to resources Recommend Favorite

The Cure Fraction of Glioblastoma Multiforme

By  

Neuroepidemiology, Vol. 39, Iss. 1, 2012-07 ,pp. : 63-69

Karger

Access to resources Recommend Favorite

Prognostic factors in glioblastoma multiforme patients receiving high-dose particle radiotherapy or conventional radiotherapy

By MATSUDA M   YAMAMOTO T   ISHIKAWA E   NAKAI K   ZABORONOK A   TAKANO S   MATSUMURA A  

British Journal of Radiology, Vol. 84, Iss. 1, 2011-12 ,pp. : 54-60

British Institute of Radiology

Access to resources Recommend Favorite

A change in the apparent diffusion coefficient after treatment with bevacizumab is associated with decreased survival in patients with recurrent glioblastoma multiforme

By PALDINO M J   DESJARDINS A   FRIEDMAN H S   VREDENBURGH J J   BARBORIAK D P  

British Journal of Radiology, Vol. 85, Iss. 1012, 2012-04 ,pp. : 382-389

British Institute of Radiology

Access to resources Recommend Favorite

Glioblastoma multiforme with atypical diffusion-weighted MR findings

By Hakyemez B   Erdogan C   Yildirim N   Parlak M  

British Journal of Radiology, Vol. 78, Iss. 935, 2005-11 ,pp. : 989-992

British Institute of Radiology

Access to resources Recommend Favorite